These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24548552)

  • 21. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
    Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
    Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin.
    Kim EJ; Ozonoff A; Hylek EM; Berlowitz DR; Ash AS; Miller DR; Zhao S; Reisman JI; Jasuja GK; Rose AJ
    Thromb Haemost; 2015 Jul; 114(1):70-7. PubMed ID: 25948532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of anticoagulation with warfarin across Kuwait.
    Zubaid M; Saad H; Ridha M; Mohanan Nair KK; Rashed W; Alhamdan R; Alenezi F; Maghami M; Sadek A
    Hellenic J Cardiol; 2013; 54(2):102-6. PubMed ID: 23557609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
    Qualls LG; Greiner MA; Eapen ZJ; Fonarow GC; Mills RM; Klaskala W; Hernandez AF; Curtis LH
    Clin Cardiol; 2013 Dec; 36(12):757-65. PubMed ID: 24114926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center.
    Baker JW; Pierce KL; Ryals CA
    J Manag Care Pharm; 2011 Mar; 17(2):133-42. PubMed ID: 21348546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    Int J Clin Pharm; 2015 Feb; 37(1):53-9. PubMed ID: 25428444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.
    An J; Niu F; Zheng C; Rashid N; Mendes RA; Dills D; Vo L; Singh P; Bruno A; Lang DT; Le PT; Jazdzewski KP; Aranda G
    J Manag Care Spec Pharm; 2017 Jun; 23(6):700-712. PubMed ID: 28530526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of international normalized ratio values among new warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Milentijevic D; Wang L; Baser O; Damaraju CV; Schein JR
    Blood Coagul Fibrinolysis; 2016 Dec; 27(8):899-906. PubMed ID: 26886362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.
    Barco S; Granziera S; Coppens M; Douxfils J; Nijkeuter M; Riva N; Vanassche T; Zhang G; Lin M; Kamphuisen PW; Cohen AT; Beyer-Westendorf J
    Thromb Haemost; 2019 Apr; 119(4):675-684. PubMed ID: 30731492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
    Vijenthira A; Le Gal G; Castellucci LA; Carrier M
    Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a Regional Effort to Improve Warfarin Management.
    Rose AJ; Park A; Gillespie C; Van Deusen Lukas C; Ozonoff A; Petrakis BA; Reisman JI; Borzecki AM; Benedict AJ; Lukesh WN; Schmoke TJ; Jones EA; Morreale AP; Ourth HL; Schlosser JE; Mayo-Smith MF; Allen AL; Witt DM; Helfrich CD; McCullough MB
    Ann Pharmacother; 2017 May; 51(5):373-379. PubMed ID: 28367699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation.
    Van Den Ham HA; Klungel OH; Leufkens HG; Van Staa TP
    J Thromb Haemost; 2013 Jan; 11(1):107-15. PubMed ID: 23088617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.